Targeted therapies in head and neck cancer
โ Scribed by Pol M. Specenier; Jan B. Vermorken
- Publisher
- Springer-Verlag
- Year
- 2007
- Tongue
- English
- Weight
- 459 KB
- Volume
- 2
- Category
- Article
- ISSN
- 1776-2596
No coin nor oath required. For personal study only.
๐ SIMILAR VOLUMES
## Abstract There is great potential for targeted radionuclide therapy (TRT) in the treatment of head and neck cancer. In recent years, developments in fields such as antigen screening, protein engineering, and cancer biology have facilitated the rational design of targeted pharmaceuticals, with mo
## Abstract In patients with squamous cell carcinoma of the head and neck (SCCHN), tumor recurrence, secondary tumors, and comorbidities contribute to therapy failure, and treatment approaches often are limited by their toxicity. With the incorporation of targeted therapies, the number of options a
## Abstract Head and neck cancer is a challenging disease that is expected to account for greater than 500,000 new cases worldwide in 2008. Toxicity has impeded advances in chemotherapy and radiation for head and neck cancer, and the prognosis for patients with recurrent and/or metastatic disease r